Recent Updates
Recently added Catalysts
PEN Positive Sentiment

Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024 Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2024 after market...

Key Takeaway: Penumbra, Inc. has announced a conference call scheduled for October 30, 2024, to discuss its financial results for the third quarter of 2024. The call will take place after market close at 4:30 PM Eastern Time, and a press release with the results will be issued at that time. Investors can access the call through phone or webcast, with the archive available for two weeks post-event. The company focuses on innovative thrombectomy technologies to improve medical outcomes globally.
Price reaction · baseline $191.56 (2024-10-01 close) · hit after-hours · clean, no other PEN news in the window
day 0 close · peak
+0.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Penumbra, Inc. continues to lead in thrombectomy technology.
  • The upcoming conference call indicates transparency and engagement with investors.
  • The company provides innovative solutions for serious medical conditions.

Full Press Release Details

ALAMEDA, Calif. , Oct. 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that it will host a conference call to discuss financial results for the third quarter 2024 after market close on Wednesday, October 30, 2024 at 4:30 PM Eastern Time . A press release with third quarter 2024 financial results will be issued after market close that day.
Webcast & Conference Call Information
The conference call can be accessed live over the phone by dialing (888) 596-4144 (conference id: 5872954), or the webcast can be accessed on the "Events and Presentations" section under the "Investors" tab of the Company's website at www.penumbrainc.com . The webcast will be available on the Company's website for at least two weeks following the completion of the call.
Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram , LinkedIn and X .
Investor Relations Penumbra, Inc. [email protected]

Frequently Asked Questions

When will Penumbra announce its Q3 2024 financial results?

Penumbra will announce its Q3 2024 financial results on October 30, 2024.

How can I access the conference call for Penumbra's Q3 results?

You can call (888) 596-4144 or access the webcast on their website.

What is Penumbra known for in the medical field?

Penumbra is renowned for its innovative thrombectomy technologies.

In how many countries does Penumbra provide its services?

Penumbra supports healthcare providers in over 100 countries.

Where can I find more information about Penumbra?

Visit www.penumbrainc.com for more information about Penumbra.

Last updated: Oct 2, 2024